lung cancer Archive — Page 4 of 12

April 25, 2022

Molecular testing across tumor types

The KRAS inhibitor sotorasib is newly approved for one kind of lung cancer; Vanderbilt researchers ask if it should be considered for another type if the tumor has the gene mutation it targets.

December 16, 2021

AI used to identify patients at risk for lung cancer

October 6, 2021

Pierre Massion

September 30, 2021

We are making progress

September 30, 2021

Philanthropist honored

September 30, 2021

Journal Watch